Company
Aperture Therapeutics
On a mission to cure neurodegenerative disease and delay brain aging
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Our platform identifies naturally occuring gene variants that protect against neurodegeneration. Using machine learning to mine large-scale genomic and clinical datasets, we identify and prioritize gene variants with the strongest protective effects and rapidly design oligonucleotide therapeutics mimicking their effect.
Loading relationship preview